N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Director of Pharmaceutical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USA$218k - $260k

About the Job

Requirements

  • A Ph.D. in Pharmaceutical Sciences, Pharmaceutics, Chemical Engineering, Chemistry, or a closely related discipline is strongly preferred, along with 12 years of industry experience.
  • At least 12 years of progressive pharmaceutical development experience in a biotechnology, pharmaceutical, or CDMO industry setting.
  • Deep expertise in small molecule drug product development focused on oral and topical dosage forms, especially enabled formulation development such as amorphous solid dispersions, lipid-based systems, and nano-formulations.
  • Comprehensive hands-on experience with Quality by Design methodologies, including Quality Target Product Profile definition, Critical Quality Attribute identification, Critical Material Attribute and Critical Process Parameter risk assessment, Design of Experiments, design space development, and control strategy establishment.
  • Significant late-stage development experience from Phase 2b/3 through NDA/MAA submission.
  • A proven track record of authoring and/or reviewing Chemistry, Manufacturing, and Controls regulatory submissions, including INDs, NDAs, and CTDs, and successfully responding to agency queries.
  • Direct CDMO management experience, including technical oversight, project governance, and relationship management.
  • Knowledge of lifecycle management, post-approval changes, and SUPAC guidance.
  • For Director level, demonstrated people-management experience leading a team of scientists/managers, department-level strategic planning, and budget/resource ownership across multiple concurrent programs.
  • Ability to work primarily in an office and laboratory environment, with occasional GMP manufacturing facility access.
  • Willingness to travel approximately 25%, including domestic and international trips to CDMO sites, clinical manufacturing sites, regulatory agency meetings, and scientific conferences.
  • Ability to gown for cleanroom/GMP environments.
  • Ability to anticipate technical and regulatory risks and develop proactive mitigation strategies that protect project timelines.
  • Experience managing multiple complex projects simultaneously in a fast-paced, deadline-driven environment.
  • Strong written and verbal communication skills to present complex scientific data clearly to technical and non-technical audiences, including senior leadership and regulatory agencies.

Responsibilities

  • Lead Quality by Design-based formulation and process development for small molecule drug programs focused on oral and topical dosage forms across all development phases.
  • Apply expertise in BCS Class II/IV compound development and enabling formulation technologies, including amorphous solid dispersions such as spray-dried dispersions and hot-melt extrusion, lipid-based drug delivery systems such as SMEDDS, SEDDS, and lipid suspensions, and nano-formulations to address solubility and bioavailability challenges.
  • Define and document the Quality Target Product Profile and identify Critical Quality Attributes to guide formulation strategy.
  • Conduct systematic risk assessments to identify Critical Material Attributes and Critical Process Parameters using Failure Mode and Effects Analysis and other risk assessment tools.
  • Develop and optimize manufacturing processes appropriate to the dosage form, ensuring scalability and process robustness.
  • Lead manufacturing scale-up activities from laboratory to pilot and commercial scale, ensuring robust and reproducible processes.
  • Troubleshoot manufacturing deviations, out-of-specification results, and process failures; drive root cause analysis and implement corrective actions.
  • Drive late-stage development activities from Phase 2b through commercial launch, including clinical supply manufacturing, process performance qualification, and continued process verification.
  • Author and review Chemistry, Manufacturing, and Controls sections of regulatory submissions, including INDs, NDAs, and MAAs.
  • Ensure all development activities comply with current Good Manufacturing Practice regulations and internal quality standards.
  • Manage external CDMO partnerships, including vendor qualification, technical oversight, and performance governance, to ensure project timelines, quality standards, and budget commitments are met.
  • Serve as the primary technical point of contact between pharmaceutical development and cross-functional teams, including Analytical Development, Clinical Operations, Regulatory Affairs, Quality, Supply Chain, and Commercial.
  • Provide scientific leadership and mentorship to junior scientists, associates, and project team members.
  • Drive scientific innovation and excellence as an internal and external thought leader in pharmaceutical development.
  • Build strong working relationships and influence without authority across diverse internal and external stakeholders.
  • Manage multiple complex projects simultaneously in a fast-paced, deadline-driven environment.
  • Present complex scientific data to technical and non-technical audiences, including senior leadership and regulatory agencies.
  • Lead and develop a team of scientists/managers, conduct department-level strategic planning, and own budgets and resources across multiple concurrent programs.

Desired Qualifications

  • A Ph.D. in Pharmaceutical Sciences, Pharmaceutics, Chemical Engineering, Chemistry, or a closely related discipline is strongly preferred.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs